Physician

Amy Rocky Brackeen, MD

According to 2025 Medicare claims, Amy Brackeen, MD (NPI: 1427036417) practices dermatology in the Lubbock, TX market, with the plurality of this provider's patient population coming from Lubbock, TX. This provider's primary affiliated billing organization is SKIN CANCER INSTITUTE PLLC (NPI: 1922463959; TIN: 475071248) and primary practice location at 79414-4877.

Brackeen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,359 traditional Medicare patients, billed 12,451 HCPCS/CPT codes, and received $468,936 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,017 prescription claims across 484 beneficiaries totaling $351,053 in drug costs, led by Tavaborole (Tavaborole). Open Payments data shows 79 records totaling $1,434. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $162,429 to $351,053. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$255K$511K2015 Medicare payment: $510,861 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $493,935 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $417,807 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $387,374 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $414,307 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $422,601 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $451,316 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $417,489 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $446,937 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $468,936 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,33211,926$510,861
20161,24711,387$493,935
20171,31210,685$417,807
20181,29720,139$387,374
20191,26317,049$414,307
20201,20214,282$422,601
20211,21912,682$451,316
20221,27112,498$417,489
20231,31012,882$446,937
20241,35912,451$468,936

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$188K$376K2015 Drug cost: $162,429 (USD; Tot_Drug_Cst)2016 Drug cost: $284,746 (USD; Tot_Drug_Cst)2017 Drug cost: $194,953 (USD; Tot_Drug_Cst)2018 Drug cost: $158,589 (USD; Tot_Drug_Cst)2019 Drug cost: $104,063 (USD; Tot_Drug_Cst)2020 Drug cost: $220,262 (USD; Tot_Drug_Cst)2021 Drug cost: $375,939 (USD; Tot_Drug_Cst)2022 Drug cost: $323,415 (USD; Tot_Drug_Cst)2023 Drug cost: $232,988 (USD; Tot_Drug_Cst)2024 Drug cost: $351,053 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015429922$162,429
20164491,074$284,746
2017389905$194,953
2018416884$158,589
2019386847$104,063
2020409960$220,262
2021443974$375,939
2022447946$323,415
20234741,044$232,988
20244841,017$351,053

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more445582$84
17110Destruction of skin growth, 1-14 growths528668$76
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more8391,151$58
17000Destruction of precancer skin growth, 1 growth683906$37
17003Destruction of precancer skin growth, 2-14 growths5523,824$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TavaboroleTavaborole32960$7,287
Clobetasol PropionateClobetasol Propionate1483,717$5,364
MetronidazoleMetronidazole551,568$2,702
TacrolimusTacrolimus17407$2,247
KetoconazoleKetoconazole1454,148$2,169

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.79$1,434Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Amy Rocky Brackeen, MD?

Tedicare shows public-source Medicare data for Amy Rocky Brackeen, MD (NPI 1427036417), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amy Rocky Brackeen, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amy Rocky Brackeen, MD?

Amy Rocky Brackeen, MD is linked to SKIN CANCER INSTITUTE PLLC (billing NPI 1922463959) in the available physician profile data.

Does Amy Rocky Brackeen, MD have Open Payments data?

Amy Rocky Brackeen, MD has 79 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.